Tentarix

Series-B
tentarix.com Biotech & Healthcare San Diego, United States Founded 2021 11–50 employees
Total Funding $50M
Latest Round Undisclosed Series-B
Last Announced Sep 27, 2023
Investors 4 Backers
Decision Makers 6 Available

About Tentarix

Tentarix develops conditionally active multispecific biologics with high therapeutic index for oncology and autoimmune disease. Based in San Diego.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters San Diego, United States
Year Founded 2021
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website tentarix.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @paulgrayson
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

  2. Milestone

    Company founded

    San Diego, United States

Investors & Backers

4
Samsara Biocapital
Lead
Amplitude Venture Capital
Gilead Sciences
Versant Ventures

Funding History

2 Rounds
Series-B equity · Sep 27, 2023
Series-A equity · Undisclosed

Round backers: Samsara Biocapital

$50,000,000 tentarix.com

Founders & Leadership

2

Margaret Karow

Founder

Work email & phone locked Unlock →

Paul Grayson

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts